Overview

Cann Group is building a world-class business focused on breeding, cultivating, manufacturing and supplying medicinal cannabis for sale and use within Australia and for approved export markets. Cann has established research, cultivation and GMP manufacturing facilities in Melbourne and a state-of-the-art large-scale cultivation and GMP manufacturing facility near Mildura, Victoria. Cann Group’s leading position in plant genetics, breeding, extraction, analysis and production techniques supports its objective to supply high quality, safe medicinal cannabis for a range of diseases and medical conditions. Cann’s product portfolio incorporates its proprietary Satipharm delivery system for cannabinoids.

ASX Announcements

More Announcements

Annual Report 2021

DownloadOpens in new window